愚愚学园 外文期刊互助 Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD

复制链接 | 浏览器收藏 | 打印

yuan

级别: supporter

作者资料
发送短消息
加为好友

UID: 85077
精华: 0
发帖: 137
威望: 5 点积分转换
愚愚币: 10542 YYB 在线充值
贡献值: 0 点
在线时间: 6033(小时)
注册时间: 2010-01-28
最后登录: 2018-02-06

楼主发表于: 2017-07-10 10:24

只看楼主 | 小中大

Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD

    【作者】Kenneth R. Chapman, MD, FCCP; Stephen I. Rennard, MD, FCCP; Angeli Dogra, MS; Roger Owen, PhD; Cheryl Lassen, MD; Benjamin Kramer, MD; on behalf of the INDORSE Study Investigators
    【文章标题】Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD:
A Randomized, Placebo-Controlled Study-Supplemental Materials
    【期刊名，年份，卷（期），起止页*****】Chest;  2011;140(1):68-75-Supplemental Materials
    【全文链接】http://journal.publications.chestnet.org/article.aspx?articleid=1088000&atab=10

求助！需要的是补充材料！谢谢！！